Show more...Show more...
Record Information
Version2.0
Created at2022-04-27 22:45:50 UTC
Updated at2022-04-27 22:45:51 UTC
NP-MRD IDNP0051371
Secondary Accession NumbersNone
Natural Product Identification
Common NameMaytansine
DescriptionMaytansine, also known as NSC 153858 or DM1, maytansinoid, belongs to the class of organic compounds known as macrolactams. These are cyclic amides of amino carboxylic acids, having a 1-azacycloalkan-2-one structure, or analogues having unsaturation or heteroatoms replacing one or more carbon atoms of the ring. They are nitrogen analogues (the a nitrogen atom replacing the o atom of the cyclic carboxylic acid group ) of the naturally occurring macrolides. Thus, maytansine is considered to be a macrolide. Maytansine is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Maytansine is found in Actinosynnema pretiosum, Maytenus buchananii , Maytenus confertiflorus, Gymnosporia diversifolia, Maytenus guangsinensis, Maytenus hookeri, Maytenus ovatus, Maytenus senata, Maytenus serrata and Putterlickia verrucosa. Maytansine was first documented in 1975 (PMID: 1241159). Based on a literature review a small amount of articles have been published on maytansine (PMID: 20937594) (PMID: 367597) (PMID: 3834790) (PMID: 628025).
Structure
Thumb
Synonyms
ValueSource
MaitansinaChEBI
MaitansineChEBI
MaitansinumChEBI
NSC 153858ChEBI
NSC-153858ChEBI
DM1, MaytansinoidMeSH
DM4, MaytansinoidMeSH
DMMO maytansineMeSH
DMMO-maytansineMeSH
Maytansinoid DM1MeSH
Maytansinoid DM4MeSH
MertansineMeSH
N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansineMeSH
RavtansineMeSH
SoravtansineMeSH
EmtansineMeSH
Chemical FormulaC34H46ClN3O10
Average Mass692.2000 Da
Monoisotopic Mass691.28717 Da
IUPAC Name(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1^{10,14}.0^{3,5}]hexacosa-10(26),11,13,16,18-pentaen-6-yl (2S)-2-(N-methylacetamido)propanoate
Traditional Name(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.1^{10,14}.0^{3,5}]hexacosa-10(26),11,13,16,18-pentaen-6-yl (2S)-2-(N-methylacetamido)propanoate
CAS Registry NumberNot Available
SMILES
CO[C@@H]1\C=C\C=C(C)\CC2=CC(OC)=C(Cl)C(=C2)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(C)=O)[C@]2(C)O[C@H]2[C@H](C)[C@@H]2C[C@@]1(O)NC(=O)O2
InChI Identifier
InChI=1S/C34H46ClN3O10/c1-18-11-10-12-26(45-9)34(43)17-25(46-32(42)36-34)19(2)30-33(5,48-30)27(47-31(41)20(3)37(6)21(4)39)16-28(40)38(7)23-14-22(13-18)15-24(44-8)29(23)35/h10-12,14-15,19-20,25-27,30,43H,13,16-17H2,1-9H3,(H,36,42)/b12-10+,18-11+/t19-,20+,25+,26-,27+,30+,33+,34+/m1/s1
InChI KeyWKPWGQKGSOKKOO-RSFHAFMBSA-N
Experimental Spectra
Not Available
Predicted Spectra
Chemical Shift Submissions
Not Available
Species
Species of Origin
Chemical Taxonomy
Description Belongs to the class of organic compounds known as macrolactams. These are cyclic amides of amino carboxylic acids, having a 1-azacycloalkan-2-one structure, or analogues having unsaturation or heteroatoms replacing one or more carbon atoms of the ring. They are nitrogen analogues (the a nitrogen atom replacing the o atom of the cyclic carboxylic acid group ) of the naturally occurring macrolides.
KingdomOrganic compounds
Super ClassPhenylpropanoids and polyketides
ClassMacrolactams
Sub ClassNot Available
Direct ParentMacrolactams
Alternative Parents
Substituents
  • Macrolactam
  • Alpha-amino acid ester
  • Alanine or derivatives
  • Alpha-amino acid or derivatives
  • Anisole
  • Alkyl aryl ether
  • 1,3-oxazinane
  • Oxazinane
  • Benzenoid
  • Aryl halide
  • Aryl chloride
  • Carbamic acid ester
  • Tertiary carboxylic acid amide
  • Acetamide
  • Lactam
  • Carboxamide group
  • Carboxylic acid ester
  • Carbonic acid derivative
  • Alkanolamine
  • Oxacycle
  • Azacycle
  • Organoheterocyclic compound
  • Carboxylic acid derivative
  • Dialkyl ether
  • Oxirane
  • Ether
  • Monocarboxylic acid or derivatives
  • Organopnictogen compound
  • Carbonyl group
  • Organic oxide
  • Organooxygen compound
  • Hydrocarbon derivative
  • Organic nitrogen compound
  • Organonitrogen compound
  • Organochloride
  • Organic oxygen compound
  • Organohalogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP2.31ALOGPS
logP3.03ChemAxon
logS-4.6ALOGPS
pKa (Strongest Acidic)11.39ChemAxon
pKa (Strongest Basic)-1.9ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area156.47 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity176.15 m³·mol⁻¹ChemAxon
Polarizability69.2 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDC00002351
Chemspider ID10274768
KEGG Compound IDC10606
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkMaytansine
METLIN IDNot Available
PubChem Compound5281828
PDB IDNot Available
ChEBI ID6701
Good Scents IDNot Available
References
General References
  1. Remillard S, Rebhun LI, Howie GA, Kupchan SM: Antimitotic activity of the potent tumor inhibitor maytansine. Science. 1975 Sep 19;189(4207):1002-5. doi: 10.1126/science.1241159. [PubMed:1241159 ]
  2. Lopus M, Oroudjev E, Wilson L, Wilhelm S, Widdison W, Chari R, Jordan MA: Maytansine and cellular metabolites of antibody-maytansinoid conjugates strongly suppress microtubule dynamics by binding to microtubules. Mol Cancer Ther. 2010 Oct;9(10):2689-99. doi: 10.1158/1535-7163.MCT-10-0644. [PubMed:20937594 ]
  3. Issell BF, Crooke ST: Maytansine. Cancer Treat Rev. 1978 Dec;5(4):199-207. doi: 10.1016/s0305-7372(78)80014-0. [PubMed:367597 ]
  4. Ravry MJ, Omura GA, Birch R: Phase II evaluation of maytansine (NSC 153858) in advanced cancer. A Southeastern Cancer Study Group trial. Am J Clin Oncol. 1985 Apr;8(2):148-50. doi: 10.1097/00000421-198504000-00007. [PubMed:3834790 ]
  5. Eagan RT, Ingle JN, Rubin J, Frytak S, Moertel CG: Early clinical study of an intermittent schedule for maytansine (NSC-153858): brief communication. J Natl Cancer Inst. 1978 Jan;60(1):93-6. doi: 10.1093/jnci/60.1.93. [PubMed:628025 ]